Literature DB >> 27323868

A new era of addiction treatment amplifies the stigma of disease and treatment for individuals with obesity.

N Alfaris1,2,3, T K Kyle4,5, J Nadai1,3, F C Stanford1,3,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27323868      PMCID： PMC6103629          DOI： 10.1038/ijo.2016.101

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN： 0307-0565            Impact factor:   5.095


× No keyword cloud information.
  23 in total

Review 1.  The epidemiology of obesity: the size of the problem.

Authors:  W P T James
Journal:  J Intern Med       Date:  2008-02-27       Impact factor: 8.989

2.  Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Frank L Greenway; Ken Fujioka; Raymond A Plodkowski; Sunder Mudaliar; Maria Guttadauria; Janelle Erickson; Dennis D Kim; Eduardo Dunayevich
Journal:  Lancet       Date:  2010-07-29       Impact factor: 79.321

3.  Health professionals' views of overweight people and smokers.

Authors:  E L Harvey; A J Hill
Journal:  Int J Obes Relat Metab Disord       Date:  2001-08

Review 4.  Patients' and professionals' experiences and perspectives of obesity in health-care settings: a synthesis of current research.

Authors:  Freda Mold; Angus Forbes
Journal:  Health Expect       Date:  2011-06-07       Impact factor: 3.377

5.  Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.

Authors:  Thomas A Wadden; John P Foreyt; Gary D Foster; James O Hill; Samuel Klein; Patrick M O'Neil; Michael G Perri; F Xavier Pi-Sunyer; Cheryl L Rock; Janelle S Erickson; Holly N Maier; Dennis D Kim; Eduardo Dunayevich
Journal:  Obesity (Silver Spring)       Date:  2010-06-17       Impact factor: 5.002

6.  Obesity management: Australian general practitioners' attitudes and practices.

Authors:  K Campbell; H Engel; A Timperio; C Cooper; D Crawford
Journal:  Obes Res       Date:  2000-09

7.  Rational design of a combination medication for the treatment of obesity.

Authors:  Frank L Greenway; M J Whitehouse; Maria Guttadauria; James W Anderson; Richard L Atkinson; Ken Fujioka; Kishore M Gadde; Alok K Gupta; Patrick O'Neil; Donald Schumacher; Diane Smith; Eduardo Dunayevich; Gary D Tollefson; Eckard Weber; Michael A Cowley
Journal:  Obesity (Silver Spring)       Date:  2008-11-06       Impact factor: 5.002

8.  Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?

Authors:  Loren Brener; William von Hippel; Susan Kippax
Journal:  Int J Drug Policy       Date:  2007-02-15

9.  Implicit and explicit anti-fat bias among a large sample of medical doctors by BMI, race/ethnicity and gender.

Authors:  Janice A Sabin; Maddalena Marini; Brian A Nosek
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II).

Authors:  Caroline M Apovian; Louis Aronne; Domenica Rubino; Christopher Still; Holly Wyatt; Colleen Burns; Dennis Kim; Eduardo Dunayevich
Journal:  Obesity (Silver Spring)       Date:  2013-05       Impact factor: 5.002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.